June 9, 2026 · Journal of cutaneous pathology · DOI: 10.1111/cup.70162

TFG-Containing Fusions in Melanocytic Tumors: From Polymorphic Read-Through Transcripts to Oncogenic Kinase Fusions

Listen to this summary

The authors investigate the presence and significance of TFG gene fusions in melanocytic tumors, identifying that 8.6% of a studied cohort harbored such fusions. They specifically characterize a TFG::NTRK3 fusion as indicative of a Spitz pathway and suggest that the TFG::ADGRG7 fusion may represent a benign polymorphic variant rather than a pathogenic driver. The study emphasizes the importance of accurately reporting and interpreting these molecular findings to enhance diagnosis and treatment strategies in melanocytic tumors.

Haiming Tang, Sara DiNapoli, Purvil Sukhadia, David Kim, Klaus J Busam

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play